Literature DB >> 1247996

Some biological properties and an in vivo evaluation of tyrosine phenol-lyase on growth of B-16 melanoma.

G G Meadows, J DiGiovanni, L Minor, G W Elmer.   

Abstract

Tyrosine phenol-lyase from Erwinia herbicola was purified with the goal of assessing its effect on growth of malignant melanoma. Ammonium sulfate-sodium citrate fractionation and diethylaminoethyl cellulose-hydroxylapatite chromatography were used. The purified enzyme was shown to reduce plasma tyrosine levels when administered to normal C57BL x DBA/2 F1 mice. The plasma half-life value of the enzyme was found to be 6 to 7 hr. Unlike results reported with glutaminase and asparaginase preparations, the lactate dehydrogenase-elevating virus had no significant influence on plasma clearance of tyrosine phenol-lyase. The enzyme significantly inhibited growth of established B-16 melanoma tumors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1247996

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

Review 1.  Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction.

Authors:  C A Elstad; G G Meadows; R M Abdallah
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

2.  PEG-PLA Nanocapsules Containing a Nanobiotechnological Complex of Polyhemoglobin-Tyrosinase for the Depletion of Tyrosine in Melanoma: Preparation and In Vitro Characterisation.

Authors:  Caroline Fustier; Thomas M S Chang
Journal:  J Nanomedine Biotherapeutic Discov       Date:  2012-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.